CIK 0000842023
- Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411427402
- Phone
- +1 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-01 | McManus Matthew President - Diag & Spatial Bio | Exercise or conversion | +4,621 | 9,356 | ||
| 2026-02-01 | McManus Matthew President - Diag & Spatial Bio | Shares withheld for taxes | −1,665 | $64.09 | $107K | 7,691 |
| 2026-02-01 | McManus Matthew President - Diag & Spatial Bio | Exercise or conversion · Restricted Stock Units | −4,621 | 4,620 | ||
| 2025-08-15 | McManus Matthew President - Diag & Spatial Bio | Exercise or conversion | +2,637 | 5,615 | ||
| 2025-08-15 | McManus Matthew President - Diag & Spatial Bio | Shares withheld for taxes | −880 | $53.60 | $47K | 4,735 |
| 2025-08-15 | McManus Matthew President - Diag & Spatial Bio | Exercise or conversion · Restricted Stock Units | −2,637 | 5,275 | ||
| 2025-08-15 | McManus Matthew President - Diag & Spatial Bio | Grant or award · Performance Restricted Stock Units | +19,243 | 19,243 | ||
| 2025-08-15 | McManus Matthew President - Diag & Spatial Bio | Grant or award · Restricted Stock Units | +9,622 | 9,622 | ||
| 2025-08-15 | McManus Matthew President - Diag & Spatial Bio | Grant or award · Stock Option (Right to Buy) | +24,614 | 24,614 | ||
| 2025-02-01 | McManus Matthew President - DGS | Exercise or conversion | +4,620 | 4,620 | ||
| 2025-02-01 | McManus Matthew President - DGS | Shares withheld for taxes | −1,642 | $73.55 | $121K | 2,978 |
| 2025-02-01 | McManus Matthew President - DGS | Exercise or conversion · Restricted Stock Units | −4,620 | 9,241 | ||
| 2024-08-15 | McManus Matthew President - DGS | Grant or award · Performance Restricted Stock Units | +15,825 | 15,825 | ||
| 2024-08-15 | McManus Matthew President - DGS | Grant or award · Performance Restricted Stock Units | +15,818 | 15,818 | ||
| 2024-08-15 | McManus Matthew President - DGS | Grant or award · Restricted Stock Units | +7,912 | 7,912 | ||
| 2024-08-15 | McManus Matthew President - DGS | Grant or award · Stock Option (Right to Buy) | +21,320 | 21,320 | ||
| 2024-02-01 | McManus Matthew President - DGS | Grant or award · Restricted Stock Units | +2,888 | 2,888 | ||
| 2024-02-01 | McManus Matthew President - DGS | Grant or award · Restricted Stock Units | +13,861 | 13,861 | ||
| 2024-02-01 | McManus Matthew President - DGS | Grant or award · Stock Option (Right to Buy) | +7,951 | 7,951 | ||
| 2024-02-01 | McManus Matthew President - DGS | Grant or award · Stock Option (Right to Buy) | +15,902 | 15,902 |
Page 1 of 1 · 20 trades